Recent developments

at Tullis and our portfolio companies

News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

August

13

FDA Accepts New Drug Application (NDA) to Review Midazolam Nasal Spray, an Investigational Product for the Acute Treatment of Seizure Clusters

Midazolam Nasal Spray has been granted orphan drug designation by the United States Food...

9

ElectroCore, Inc. Announces Research Collaboration with Massachusetts General Hospital to Explore Non-invasive Vagus Nerve Stimulation in Neuroinflammation

Non-invasive vagus nerve stimulation (nVNS) will be studied in preclinical settings, looking at the...

1

Next Generation NVNS Therapy GammaCore Sapphire™ Now Available For Patients with Migraine an Episodic Cluster Headache in United States

Innovative technology provides patients with convenient, easy-to-use treatment option without the potential side effects...

17

ElectroCore and UpScript Launch Program to Offfer Direct-To-Patient Telemedicine Option For GammaCore™ in the United States

gammaCore is the first FDA-cleared, nVNS therapy that can be self-administered by patients as...

13

New Research Shows Promise in Regional Deliver of CAR-T Therapy

Authors conclude delivery devices should be developed in conjunction with CAR-T therapies DENVER–(BUSINESS WIRE)–Surefire...

11

OrthoSensor Secures Aditional 510(k) Clearance

VERASENSE™ Sensor-Assisted Technology Now Approved for Use with Zimmer Biomet Persona® Knee System, enabling surgeons...

8

Alphatec Spine Disrupts Market With Acquisition Of Safeop Surgical

CARLSBAD, CA — March 8, 2018 — Alphatec Holdings, Inc. (“Alphatec” or the “Company”) (Nasdaq:...

25

Exagen Diagnostics Announces Collaboration With GSK To Drive Greater Awareness About Challenges Facing Lupus Diagnosis And Management

ALBUQUERQUE, NM and SAN DIEGO, CA — January 25, 2018 — Exagen Diagnostics, Inc....

23

Surefire Medical Appoints Mary T. Szela CEO And President

DENVER, Jan. 23, 2018 – Surefire Medical, Inc. (Surefire) today announced the appointment of Mary...

Recent developments

News

August

13

FDA Accepts New Drug Application (NDA) to Review Midazolam Nasal Spray, an Investigational Product for the Acute Treatment of Seizure Clusters

August

9

ElectroCore, Inc. Announces Research Collaboration with Massachusetts General Hospital to Explore Non-invasive Vagus Nerve Stimulation in Neuroinflammation

August

1

Next Generation NVNS Therapy GammaCore Sapphire™ Now Available For Patients with Migraine an Episodic Cluster Headache in United States

July

17

ElectroCore and UpScript Launch Program to Offfer Direct-To-Patient Telemedicine Option For GammaCore™ in the United States

July

13

New Research Shows Promise in Regional Deliver of CAR-T Therapy

June

11

OrthoSensor Secures Aditional 510(k) Clearance

March

8

Alphatec Spine Disrupts Market With Acquisition Of Safeop Surgical

January

25

Exagen Diagnostics Announces Collaboration With GSK To Drive Greater Awareness About Challenges Facing Lupus Diagnosis And Management

January

23

Surefire Medical Appoints Mary T. Szela CEO And President